https://www.selleckchem.com/CDK.html
Collectively, targeting FBP1 is a promising therapeutic strategy of high Evi1 AML.All academic medical specialties have the obligation to continuously create new knowledge that will improve patient care and outcomes. Emergency medicine (EM) is no exception. Since its origins over 50 year ago, EM has struggled to fulfill its research mission. EM ranks last among clinical specialties in the percent of medical school faculty who are NIH-funded principal investigators (PIs) (1.7%) and percent of medical school departments with NIH-funded PIs (33%). Alth